| Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran S Farajnia, MY Alikhani, R Ghotaslou, B Naghili, A Nakhlband International journal of infectious diseases 13 (2), 140-144, 2009 | 350 | 2009 |
| Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections Y Sharifi, A Hasani, R Ghotaslou, B Naghili, M Aghazadeh, M Milani, ... Advanced pharmaceutical bulletin 3 (1), 197, 2013 | 106 | 2013 |
| Detection of metallo-β-lactamase–encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran S Yousefi, S Farajnia, MR Nahaei, MT Akhi, R Ghotaslou, MH Soroush, ... Diagnostic microbiology and infectious disease 68 (3), 322-325, 2010 | 102 | 2010 |
| Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran N Sohrabi, S Farajnia, MT Akhi, MR Nahaei, B Naghili, A Peymani, Z Amiri, ... Microbial drug resistance 18 (4), 385-389, 2012 | 85 | 2012 |
| To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis M Yekani, HB Baghi, B Naghili, SZ Vahed, J Sóki, MY Memar Microbial pathogenesis 149, 104506, 2020 | 53 | 2020 |
| Molecular screening of virulence genes in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolated from clinical specimens in Northwest Iran A Hasani, Y Sharifi, R Ghotaslou, B Naghili, M Aghazadeh, M Milani, ... Indian journal of medical microbiology 30 (2), 175-181, 2012 | 51 | 2012 |
| The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies MR Ranjkesh, B Naghili, M Goldust, E Rezaee Annals of parasitology 59 (4), 2013 | 49 | 2013 |
| A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines MM Pourseif, S Parvizpour, B Jafari, J Dehghani, B Naghili, Y Omidi BioImpacts: BI 11 (1), 65, 2021 | 47 | 2021 |
| Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran A Hasani, V Sheikhalizadeh, A Hasani, B Naghili, V Valizadeh, ... Iranian Journal of Microbiology 5 (1), 56, 2013 | 47 | 2013 |
| The central role of the SOS DNA repair system in antibiotics resistance: A new target for a new infectious treatment strategy MY Memar, M Yekani, G Celenza, V Poortahmasebi, B Naghili, P Bellio, ... Life Sciences 262, 118562, 2020 | 40 | 2020 |
| Acute Q fever in febrile patients in northwestern of Iran S Esmaeili, F Golzar, E Ayubi, B Naghili, E Mostafavi PLoS neglected tropical diseases 11 (4), e0005535, 2017 | 35 | 2017 |
| Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey R El-Sokkary, S Uysal, H Erdem, R Kullar, AU Pekok, F Amer, S Grgić, ... European Journal of Clinical Microbiology & Infectious Diseases 40 (11 …, 2021 | 34 | 2021 |
| A novel in silico minigene vaccine based on CD4+ T-helper and B-cell epitopes of EG95 isolates for vaccination against cystic echinococcosis MM Pourseif, G Moghaddam, B Naghili, N Saeedi, S Parvizpour, ... Computational Biology and Chemistry 72, 150-163, 2018 | 34 | 2018 |
| Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates … MT Akhi, Y Khalili, R Ghotaslou, HS Kafil, S Yousefi, B Nagili, HR Goli Journal of Chemotherapy 29 (3), 144-149, 2017 | 33 | 2017 |
| Managing adult patients with infectious diseases in emergency departments: international ID-IRI study H Erdem, S Hargreaves, H Ankarali, H Caskurlu, SA Ceviker, ... Journal of Chemotherapy 33 (5), 302-318, 2021 | 30 | 2021 |
| IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in Early S Pour Abolghasem, MR Bonyadi, Z Babaloo, A Porhasan, B Nagili, ... Iranian Journal of Immunology 8 (4), 251-255, 2011 | 29 | 2011 |
| Efficiency of polymerase chain reaction for the diagnosis of tuberculous meningitis. A Rafi, B Naghily The Southeast Asian Journal of Tropical Medicine and Public Health 34 (2 …, 2003 | 27 | 2003 |
| Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 F Lotfi, M Akbarzadeh-Khiavi, Z Lotfi, L Rahbarnia, A Safary, H Zarredar, ... Infection 49 (6), 1133-1147, 2021 | 26 | 2021 |
| Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection S Farajnia, SN Peerayeh, A Tanomand, J Majidi, G Goudarzi, B Naghili, ... Canadian Journal of Microbiology 61 (1), 60-64, 2015 | 26 | 2015 |
| Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran MT Akhi, Y Khalili, R Ghotaslou, S Yousefi, HS Kafil, B Naghili, ... Microbial Drug Resistance 24 (2), 126-135, 2018 | 24 | 2018 |
